JMKE Jersey Mike's | $21.80 -0.3% | 9/11/2026 | | Boost Price Target | $28.00 ➝ $29.00 | Buy | 00.00% | View details for Guggenheim rating of Jersey Mike’s (NYSE:JMKE) on 9/11/2026 |
REF Reformation | $13.96 +6.2% | 9/11/2026 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for Guggenheim rating of Reformation (NYSE:REF) on 9/11/2026 |
RH RH | $135.09 +0.8% | 9/11/2026 | | Reiterated Rating | $200.00 | Buy | 00.00% | View details for Guggenheim rating of RH (NYSE:RH) on 9/11/2026 |
PHVS Pharvaris | $38.45 +2.5% | 9/10/2026 | | Boost Price Target | $40.00 ➝ $44.00 | Buy | 00.00% | View details for Guggenheim rating of Pharvaris (NASDAQ:PHVS) on 9/10/2026 |
IDYA IDEAYA Biosciences | $37.80 +0.9% | 9/9/2026 | | Boost Price Target | $54.00 ➝ $57.00 | Buy | 00.00% | View details for Guggenheim rating of IDEAYA Biosciences (NASDAQ:IDYA) on 9/9/2026 |
ROIV Roivant Sciences | $41.05 +0.3% | 9/9/2026 | | Boost Price Target | $42.00 ➝ $46.00 | Buy | 00.00% | View details for Guggenheim rating of Roivant Sciences (NASDAQ:ROIV) on 9/9/2026 |
ORCL Oracle | $151.48 -1.0% | 9/8/2026 | | Reiterated Rating | $400.00 | Buy | 00.00% | View details for Guggenheim rating of Oracle (NYSE:ORCL) on 9/8/2026 |
MRK Merck & Co., Inc. | $144.21 -0.3% | 9/8/2026 | | Boost Price Target | $146.00 ➝ $170.00 | Buy | 00.00% | View details for Guggenheim rating of Merck & Co., Inc. (NYSE:MRK) on 9/8/2026 |
XE X-Energy | $14.93 -5.7% | 9/8/2026 | | Reiterated Rating | $57.00 | Buy | 00.00% | View details for Guggenheim rating of X-Energy (NASDAQ:XE) on 9/8/2026 |
IOT Samsara | $38.06 -1.0% | 9/4/2026 | | Boost Price Target | $45.00 ➝ $51.00 | Buy | 00.00% | View details for Guggenheim rating of Samsara (NYSE:IOT) on 9/4/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
ZS Zscaler | $163.87 +0.2% | 9/4/2026 | | Reiterated Rating | $214.00 | Buy | 00.00% | View details for Guggenheim rating of Zscaler (NASDAQ:ZS) on 9/4/2026 |
LULU lululemon athletica | $98.24 +1.4% | 9/4/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of lululemon athletica (NASDAQ:LULU) on 9/4/2026 |
UBER Uber Technologies | $71.59 -1.3% | 9/3/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Uber Technologies (NYSE:UBER) on 9/3/2026 |
FIVE Five Below | $245.63 +1.8% | 9/3/2026 | | Boost Price Target | $250.00 ➝ $290.00 | Buy | 00.00% | View details for Guggenheim rating of Five Below (NASDAQ:FIVE) on 9/3/2026 |
ALMS Alumis | $9.22 -6.9% | 9/3/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Guggenheim rating of Alumis (NASDAQ:ALMS) on 9/3/2026 |
SNOW Snowflake | $324.84 -1.5% | 9/3/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of Snowflake (NYSE:SNOW) on 9/3/2026 |
EROC ERock | $12.70 +7.0% | 9/2/2026 | | Lower Price Target | $23.00 ➝ $20.00 | Buy | 00.00% | View details for Guggenheim rating of ERock (NYSE:EROC) on 9/2/2026 |
SPHR Sphere Entertainment | $142.34 +0.3% | 9/2/2026 | | Boost Price Target | $193.00 ➝ $208.00 | Buy | 00.00% | View details for Guggenheim rating of Sphere Entertainment (NYSE:SPHR) on 9/2/2026 |
SNAP Snap | $5.69 +3.0% | 9/2/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of Snap (NYSE:SNAP) on 9/2/2026 |
PANW Palo Alto Networks | $328.03 -3.1% | 9/2/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of Palo Alto Networks (NASDAQ:PANW) on 9/2/2026 |
GTLB GitLab | $46.92 -0.8% | 9/2/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of GitLab (NASDAQ:GTLB) on 9/2/2026 |
MDB MongoDB | $362.53 -3.0% | 9/2/2026 | | Reiterated Rating | $560.00 | Buy | 00.00% | View details for Guggenheim rating of MongoDB (NASDAQ:MDB) on 9/2/2026 |
BLSM BlossomHill Therapeutics | $20.87 -3.0% | 9/1/2026 | | Initiated Coverage | $30.00 | Buy | 00.00% | View details for Guggenheim rating of BlossomHill Therapeutics (NASDAQ:BLSM) on 9/1/2026 |
LTGO Latigo Biotherapeutics | $22.18 +3.0% | 9/1/2026 | | Initiated Coverage | $50.00 | Buy | 00.00% | View details for Guggenheim rating of Latigo Biotherapeutics (NASDAQ:LTGO) on 9/1/2026 |
BLSM BlossomHill Therapeutics | $20.87 -3.0% | 9/1/2026 | | Initiated Coverage | $30.00 | Buy | 00.00% | View details for Guggenheim rating of BlossomHill Therapeutics (NASDAQ:BLSM) on 9/1/2026 |
LTGO Latigo Biotherapeutics | $22.18 +3.0% | 9/1/2026 | | Initiated Coverage | $50.00 | Buy | 00.00% | View details for Guggenheim rating of Latigo Biotherapeutics (NASDAQ:LTGO) on 9/1/2026 |
TJX TJX Companies | $126.32 -0.1% | 8/31/2026 | | Set Price Target | $152.00 | | 00.00% | View details for Guggenheim rating of TJX Companies (NYSE:TJX) on 8/31/2026 |
DG Dollar General | $124.69 +1.4% | 8/31/2026 | | Reiterated Rating | $140.00 | Buy | 00.00% | View details for Guggenheim rating of Dollar General (NYSE:DG) on 8/31/2026 |
TENX Tenax Therapeutics | $1.90 -2.8% | 8/31/2026 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Guggenheim rating of Tenax Therapeutics (NASDAQ:TENX) on 8/31/2026 |
KYMR Kymera Therapeutics | $115.39 -1.4% | 8/31/2026 | | Boost Price Target | $135.00 ➝ $170.00 | Buy | 00.00% | View details for Guggenheim rating of Kymera Therapeutics (NASDAQ:KYMR) on 8/31/2026 |
ESTC Elastic | $83.61 +0.2% | 8/28/2026 | | Boost Price Target | $106.00 ➝ $120.00 | Buy | 00.00% | View details for Guggenheim rating of Elastic (NYSE:ESTC) on 8/28/2026 |
ADSK Autodesk | $212.59 +0.5% | 8/28/2026 | | Boost Price Target | $277.00 ➝ $283.00 | Buy | 00.00% | View details for Guggenheim rating of Autodesk (NASDAQ:ADSK) on 8/28/2026 |
BBY Best Buy | $91.19 +3.5% | 8/28/2026 | | Boost Price Target | $90.00 ➝ $95.00 | Buy | 00.00% | View details for Guggenheim rating of Best Buy (NYSE:BBY) on 8/28/2026 |
RVMD Revolution Medicines | $203.91 +0.3% | 8/28/2026 | | Boost Price Target | $240.00 ➝ $275.00 | Buy | 00.00% | View details for Guggenheim rating of Revolution Medicines (NASDAQ:RVMD) on 8/28/2026 |
CRM Salesforce | $248.30 +2.2% | 8/27/2026 | | Reiterated Rating | $228.00 | Buy | 00.00% | View details for Guggenheim rating of Salesforce (NYSE:CRM) on 8/27/2026 |
OKTA Okta | $166.43 -2.7% | 8/27/2026 | | Set Price Target | $162.00 ➝ $188.00 | Buy | 00.00% | View details for Guggenheim rating of Okta (NASDAQ:OKTA) on 8/27/2026 |
AMLX Amylyx Pharmaceuticals | $32.11 +0.1% | 8/27/2026 | | Boost Price Target | $55.00 ➝ $57.00 | Buy | 00.00% | View details for Guggenheim rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 8/27/2026 |
CRWD CrowdStrike | $205.90 -1.4% | 8/27/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of CrowdStrike (NASDAQ:CRWD) on 8/27/2026 |
GWRE Guidewire Software | $141.09 +0.7% | 8/27/2026 | | Boost Price Target | $180.00 ➝ $210.00 | Buy | 00.00% | View details for Guggenheim rating of Guidewire Software (NYSE:GWRE) on 8/27/2026 |
P Everpure | $97.43 +3.5% | 8/27/2026 | | Reiterated Rating | $150.00 | Buy | 00.00% | View details for Guggenheim rating of Everpure (NYSE:P) on 8/27/2026 |
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad) Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain. Get the name and ticker of Louis Navellier's #1 AI stock free |
VEEV Veeva Systems | $262.71 +0.7% | 8/27/2026 | | Boost Price Target | $276.00 ➝ $310.00 | Buy | 00.00% | View details for Guggenheim rating of Veeva Systems (NYSE:VEEV) on 8/27/2026 |
WSM Williams-Sonoma | $225.89 +1.0% | 8/27/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of Williams-Sonoma (NYSE:WSM) on 8/27/2026 |
DKS DICK'S Sporting Goods | $134.98 +1.4% | 8/26/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of DICK’S Sporting Goods (NYSE:DKS) on 8/26/2026 |
SMMT Summit Therapeutics | $17.57 +3.3% | 8/26/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Summit Therapeutics (NASDAQ:SMMT) on 8/26/2026 |
FOX FOX | $58.44 +0.6% | 8/25/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of FOX (NASDAQ:FOX) on 8/25/2026 |
DLTR Dollar Tree | $117.23 -1.2% | 8/25/2026 | | Boost Price Target | $135.00 ➝ $145.00 | Buy | 00.00% | View details for Guggenheim rating of Dollar Tree (NASDAQ:DLTR) on 8/25/2026 |
FOXA FOX | $65.87 +1.1% | 8/25/2026 | | Reiterated Rating | $85.00 | Buy | 00.00% | View details for Guggenheim rating of FOX (NASDAQ:FOXA) on 8/25/2026 |
GLUE Monte Rosa Therapeutics | $14.15 -1.2% | 8/25/2026 | | Reiterated Rating | $28.00 | Buy | 00.00% | View details for Guggenheim rating of Monte Rosa Therapeutics (NASDAQ:GLUE) on 8/25/2026 |
SNOW Snowflake | $324.84 -1.5% | 8/24/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of Snowflake (NYSE:SNOW) on 8/24/2026 |
REF Reformation | $13.96 +6.2% | 8/24/2026 | | Initiated Coverage | $20.00 | Buy | 00.00% | View details for Guggenheim rating of Reformation (NYSE:REF) on 8/24/2026 |
TWST Twist Bioscience | $128.08 +1.0% | 8/24/2026 | | Reiterated Rating | | Buy | 00.00% | View details for Guggenheim rating of Twist Bioscience (NASDAQ:TWST) on 8/24/2026 |
RBRK Rubrik | $86.16 -3.1% | 8/24/2026 | | Boost Price Target | $110.00 ➝ $116.00 | Buy | 00.00% | View details for Guggenheim rating of Rubrik (NYSE:RBRK) on 8/24/2026 |
ELOX Eloxx Pharmaceuticals | $15.80 -2.9% | 8/24/2026 | | Reiterated Rating | $43.00 | Buy | 00.00% | View details for Guggenheim rating of Eloxx Pharmaceuticals (NASDAQ:ELOX) on 8/24/2026 |
JMKE Jersey Mike's | $21.80 -0.3% | 8/24/2026 | | Initiated Coverage | $28.00 | Buy | 00.00% | View details for Guggenheim rating of Jersey Mike’s (NYSE:JMKE) on 8/24/2026 |
REF Reformation | $13.96 +6.2% | 8/24/2026 | | Initiated Coverage | $20.00 | Buy | 00.00% | View details for Guggenheim rating of Reformation (NYSE:REF) on 8/24/2026 |
ZS Zscaler | $163.87 +0.2% | 8/24/2026 | | Reiterated Rating | $214.00 | Buy | 00.00% | View details for Guggenheim rating of Zscaler (NASDAQ:ZS) on 8/24/2026 |
WDAY Workday | $185.78 +0.4% | 8/21/2026 | | Reiterated Rating | $275.00 | Buy | 00.00% | View details for Guggenheim rating of Workday (NASDAQ:WDAY) on 8/21/2026 |
AAP Advance Auto Parts | $45.02 +4.0% | 8/21/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of Advance Auto Parts (NYSE:AAP) on 8/21/2026 |
LOW Lowe's Companies | $197.01 +0.2% | 8/21/2026 | | Lower Price Target | $300.00 ➝ $275.00 | Buy | 00.00% | View details for Guggenheim rating of Lowe’s Companies (NYSE:LOW) on 8/21/2026 |
WMT Walmart | $107.12 +1.3% | 8/21/2026 | | Set Price Target | $135.00 ➝ $130.00 | Buy | 00.00% | View details for Guggenheim rating of Walmart (NASDAQ:WMT) on 8/21/2026 |
CRWD CrowdStrike | $205.90 -1.4% | 8/20/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of CrowdStrike (NASDAQ:CRWD) on 8/20/2026 |
OKTA Okta | $166.43 -2.7% | 8/20/2026 | | Boost Price Target | $138.00 ➝ $162.00 | Buy | 00.00% | View details for Guggenheim rating of Okta (NASDAQ:OKTA) on 8/20/2026 |
TGT Target | $155.52 -0.1% | 8/20/2026 | | Boost Price Target | $150.00 ➝ $175.00 | Buy | 00.00% | View details for Guggenheim rating of Target (NYSE:TGT) on 8/20/2026 |
VEEV Veeva Systems | $262.71 +0.7% | 8/20/2026 | | Boost Price Target | $232.00 ➝ $276.00 | Buy | 00.00% | View details for Guggenheim rating of Veeva Systems (NYSE:VEEV) on 8/20/2026 |
FRNM Freenome | $14.55 -1.6% | 8/20/2026 | | Initiated Coverage | $21.00 | Buy | 00.00% | View details for Guggenheim rating of Freenome (NASDAQ:FRNM) on 8/20/2026 |
ADSK Autodesk | $212.59 +0.5% | 8/20/2026 | | Boost Price Target | $245.00 ➝ $277.00 | Buy | 00.00% | View details for Guggenheim rating of Autodesk (NASDAQ:ADSK) on 8/20/2026 |
S SentinelOne | $19.76 -0.3% | 8/20/2026 | | Boost Price Target | $24.00 ➝ $28.00 | Buy | 00.00% | View details for Guggenheim rating of SentinelOne (NYSE:S) on 8/20/2026 |
CALC CalciMedica | $2.06 -3.0% | 8/20/2026 | | Initiated Coverage | | Buy | 00.00% | View details for Guggenheim rating of CalciMedica (NASDAQ:CALC) on 8/20/2026 |
CRM Salesforce | $248.30 +2.2% | 8/20/2026 | | Reiterated Rating | $228.00 | Buy | 00.00% | View details for Guggenheim rating of Salesforce (NYSE:CRM) on 8/20/2026 |
FRNM Freenome | $14.55 -1.6% | 8/20/2026 | | Initiated Coverage | $21.00 | Buy | 00.00% | View details for Guggenheim rating of Freenome (NASDAQ:FRNM) on 8/20/2026 |
GTLB GitLab | $46.92 -0.8% | 8/19/2026 | | Reiterated Rating | | Neutral | 00.00% | View details for Guggenheim rating of GitLab (NASDAQ:GTLB) on 8/19/2026 |
AMLX Amylyx Pharmaceuticals | $32.11 +0.1% | 8/19/2026 | | Boost Price Target | $40.00 ➝ $55.00 | Buy | 00.00% | View details for Guggenheim rating of Amylyx Pharmaceuticals (NASDAQ:AMLX) on 8/19/2026 |
ESTC Elastic | $83.61 +0.2% | 8/19/2026 | | Reiterated Rating | $106.00 | Buy | 00.00% | View details for Guggenheim rating of Elastic (NYSE:ESTC) on 8/19/2026 |
HD Home Depot | $309.02 +1.1% | 8/19/2026 | | Reiterated Rating | $425.00 | Buy | 00.00% | View details for Guggenheim rating of Home Depot (NYSE:HD) on 8/19/2026 |
SCTX Scribe Therapeutics | $30.50 +3.5% | 8/18/2026 | | Initiated Coverage | $50.00 | Buy | 00.00% | View details for Guggenheim rating of Scribe Therapeutics (NASDAQ:SCTX) on 8/18/2026 |
MDB MongoDB | $362.53 -3.0% | 8/18/2026 | | Boost Price Target | $475.00 ➝ $560.00 | Buy | 00.00% | View details for Guggenheim rating of MongoDB (NASDAQ:MDB) on 8/18/2026 |
LGN LGN | $56.62 +5.7% | 8/18/2026 | | Reiterated Rating | $115.00 | Buy | 00.00% | View details for Guggenheim rating of LGN (NASDAQ:LGN) on 8/18/2026 |
SCTX Scribe Therapeutics | $30.50 +3.5% | 8/18/2026 | | Initiated Coverage | $50.00 | Buy | 00.00% | View details for Guggenheim rating of Scribe Therapeutics (NASDAQ:SCTX) on 8/18/2026 |
CELC Celcuity | $83.96 -1.8% | 8/17/2026 | | Boost Price Target | $165.00 ➝ $175.00 | Buy | 00.00% | View details for Guggenheim rating of Celcuity (NASDAQ:CELC) on 8/17/2026 |
SPRB Spruce Biosciences | $54.24 -0.2% | 8/17/2026 | | Reiterated Rating | $123.00 ➝ $104.00 | Buy | 00.00% | View details for Guggenheim rating of Spruce Biosciences (NASDAQ:SPRB) on 8/17/2026 |
WMT Walmart | $107.12 +1.3% | 8/17/2026 | | Reiterated Rating | $137.00 ➝ $135.00 | Buy | 00.00% | View details for Guggenheim rating of Walmart (NASDAQ:WMT) on 8/17/2026 |
YSWY Yesway | $22.71 +2.6% | 8/17/2026 | | Boost Price Target | $30.00 ➝ $32.00 | Buy | 00.00% | View details for Guggenheim rating of Yesway (NASDAQ:YSWY) on 8/17/2026 |
ADCT ADC Therapeutics | $1.08 -3.2% | 8/17/2026 | | Lower Price Target | $5.00 | Buy | 00.00% | View details for Guggenheim rating of ADC Therapeutics (NYSE:ADCT) on 8/17/2026 |
FWONK Liberty Media Corporation - Liberty Formula One Series C | $95.74 +0.3% | 8/17/2026 | | Boost Price Target | $125.00 ➝ $134.00 | Buy | 00.00% | View details for Guggenheim rating of Liberty Media Corporation - Liberty Formula One Series C (NASDAQ:FWONK) on 8/17/2026 |
FWONA Liberty Media Corporation - Liberty Formula One Series A | $87.23 +0.3% | 8/14/2026 | | Boost Price Target | $116.00 ➝ $124.00 | Buy | 00.00% | View details for Guggenheim rating of Liberty Media Corporation - Liberty Formula One Series A (NASDAQ:FWONA) on 8/14/2026 |
BIRK Birkenstock | $31.02 +1.1% | 8/14/2026 | | Reiterated Rating | $60.00 | Buy | 00.00% | View details for Guggenheim rating of Birkenstock (NYSE:BIRK) on 8/14/2026 |
GLOB Globant | $37.58 +2.4% | 8/14/2026 | | Lower Price Target | $55.00 ➝ $50.00 | Buy | 00.00% | View details for Guggenheim rating of Globant (NYSE:GLOB) on 8/14/2026 |
MSGS Madison Square Garden | $388.51 -0.9% | 8/14/2026 | | Boost Price Target | $522.00 ➝ $584.00 | Buy | 00.00% | View details for Guggenheim rating of Madison Square Garden (NYSE:MSGS) on 8/14/2026 |
ZBIO Zenas BioPharma | $31.46 +1.1% | 8/14/2026 | | Reiterated Rating | $55.00 | Buy | 00.00% | View details for Guggenheim rating of Zenas BioPharma (NASDAQ:ZBIO) on 8/14/2026 |
PHVS Pharvaris | $38.45 +2.5% | 8/13/2026 | | Boost Price Target | $39.00 ➝ $40.00 | Buy | 00.00% | View details for Guggenheim rating of Pharvaris (NASDAQ:PHVS) on 8/13/2026 |
The $15 Gold Fund That Pays Up to $1,152/Month (Ad) Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required.
Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away. Discover the gold income fund before the next payout date |
UNCY Unicycive Therapeutics | $5.32 +0.1% | 8/13/2026 | | Reiterated Rating | $37.00 ➝ $25.00 | Buy | 00.00% | View details for Guggenheim rating of Unicycive Therapeutics (NASDAQ:UNCY) on 8/13/2026 |
ERAS Erasca | $16.15 +0.7% | 8/13/2026 | | Boost Price Target | $20.00 ➝ $21.00 | Buy | 00.00% | View details for Guggenheim rating of Erasca (NASDAQ:ERAS) on 8/13/2026 |
P Everpure | $97.43 +3.5% | 8/13/2026 | | Boost Price Target | $115.00 ➝ $150.00 | Buy | 00.00% | View details for Guggenheim rating of Everpure (NYSE:P) on 8/13/2026 |
SCYX SCYNEXIS | $4.86 +3.3% | 8/13/2026 | | Reiterated Rating | $24.00 ➝ $33.00 | Buy | 00.00% | View details for Guggenheim rating of SCYNEXIS (NASDAQ:SCYX) on 8/13/2026 |
CAVA CAVA Group | $55.82 +3.4% | 8/13/2026 | | Lower Price Target | $100.00 ➝ $95.00 | Buy | 00.00% | View details for Guggenheim rating of CAVA Group (NYSE:CAVA) on 8/13/2026 |
STUB STUB | $6.05 +1.6% | 8/13/2026 | | Lower Price Target | $12.50 ➝ $11.00 | Buy | 00.00% | View details for Guggenheim rating of STUB (NYSE:STUB) on 8/13/2026 |
AVBP ArriVent BioPharma | $28.80 +0.3% | 8/13/2026 | | Reiterated Rating | $45.00 | Buy | 00.00% | View details for Guggenheim rating of ArriVent BioPharma (NASDAQ:AVBP) on 8/13/2026 |
MSGE Madison Square Garden Entertainment | $77.94 +2.9% | 8/12/2026 | | Boost Price Target | $82.00 ➝ $103.00 | Buy | 00.00% | View details for Guggenheim rating of Madison Square Garden Entertainment (NYSE:MSGE) on 8/12/2026 |
COGT Cogent Biosciences | $33.31 -2.3% | 8/12/2026 | | Boost Price Target | $45.00 ➝ $52.00 | Buy | 00.00% | View details for Guggenheim rating of Cogent Biosciences (NASDAQ:COGT) on 8/12/2026 |
NGNE Neurogene | $36.08 -0.1% | 8/12/2026 | | Boost Price Target | $69.00 ➝ $81.00 | Buy | 00.00% | View details for Guggenheim rating of Neurogene (NASDAQ:NGNE) on 8/12/2026 |